Experimental traumatic brain injury (TBI) results in a significant loss of cortical tissue at the site of injury, and in the ensuing hours and days a secondary injury exacerbates this primary injury, resulting in significant neurological dysfunction. The mechanism of the secondary injury is not well understood, but evidence implicates a critical role for mitochondria in this cascade. This mitochondrial dysfunction is believed to involve excitotoxicity, disruption of Ca 2؉ homeostasis, production of reactive oxygen species (ROS), ATP depletion, oxidative damage of mitochondrial proteins, and an overall breakdown of mitochondrial bioenergetics. Although oxidative damage occurs following TBI, the identities of proteins undergoing oxidative modification after TBI have not been investigated. In the present study, we utilized the 3-h post-injury controlled cortical impact model of experimental TBI in 20 young adult male Sprague-Dawley rats, coupled with proteomics to identify specific mitochondrial fraction proteins from the cortex and hippocampus that were oxidatively modified after TBI. We identified, from the cortex, pyruvate dehydrogenase, voltage-dependent anion channel, fumarate hydratase 1, ATP synthase, and prohibitin. From the hippocampus, we identified cytochrome C oxidase Va, isovaleryl coenzyme A dehydrogenase, enolase-1, and glyceraldehyde-3-phosphate dehydrogenase as proteins that had undergone oxidative modification following TBI. In addition, we have also shown that, following TBI, there is a reduction in the activities of pyruvate dehydrogenase (PDH), complex I, and complex IV. These findings demonstrate that, following TBI, several proteins involved in mitochondrial bioenergetics are highly oxidatively modified, which may possibly underlie the massive breakdown of mitochondrial energetics and eventual cell death known to occur in this model. The identification of these proteins provides new insights into the mechanisms that take place following TBI and may provide avenues for possible therapeutic interventions after TBI.
INTRODUCTION
T RAUMATIC BRAIN INJURY (TBI) is a serious health care problem in the United States, with more than 400,000 individuals hospitalized each year and an estimated annual cost of $25 billion (Tibbs et al., 1998; McNair, 1999) . There is therefore an urgent need for therapeutic interventions for TBI. The discovery and development of possible targets for therapeutics will only be achieved by developing a better understanding of the mechanisms involving the pathogenesis of TBI.
One underlying mechanism that may be involved in the rapid and significant loss of cortical tissue that occurs following TBI involves mitochondria (Vink et al., 1990; Xiong et al., 1997; Lifshitz et al., 2004) . TBI-induced neuropathology proceeds in a biphasic manner, consisting of a primary insult accompanied by a secondary injury that proceeds for minutes, hours, and days (Sullivan et al., 1998 Hall et al., 2005) . TBI neuropathology is believed to involve disruptions in excitatory amino acids and Ca 2ϩ homeostasis, production of reactive oxygen species (ROS), and an overall breakdown in mitochondria bioenergetics (Sullivan et al., 1998 (Sullivan et al., , 2005 Scheff et al., 1999; Friberg et al., 2002; Lifshitz et al., 2004) . Other than their primary role of ATP generation, mitochondria also play a role in cell survival, activate apoptotic cascades, and act as high capacity Ca 2ϩ repositories to maintain Ca 2ϩ homeostasis for normal cell functions (Wallace, 1999; Nicholls et al., 2000 Nicholls et al., , 2002 Szewczyk et al., 2002) . Following neuronal injury, excessive uptake of Ca 2ϩ and eventual overload increases mitochondrial production of ROS, which may induce the opening of the mitochondrial permeability transition pore (mPTP), a release of cytochrome C, and inhibition of ATP production, and ultimately lead to cell death (Nicholls et al., 2000; Rego et al., 2003; Lifshitz et al., 2004; Sullivan et al., 2005) .
Mitochondrial ROS are produced as byproducts of ATP synthesis when electrons escape from the electron transport system. Following TBI or traumatic spinal injury, there is a well-documented increase in the production of ROS (Braughler et al., 1992; Hall et al., 1999; Sullivan et al., 1998 Sullivan et al., , 1999 Sullivan et al., , 2000a Aksenova et al., 2002; Zhang et al., 2005) . This generation of ROS and eventual oxidative damage leads to the inactivation of various enzymes in the cell. In particular, mitochondrial enzymes have been shown to be primary targets of oxidative stress in most neurodegenerative diseases and disorders (Gibson et al., 1998 (Gibson et al., , 2004 Martin et al., 2005; Poon et al., 2005) . This inactivation is believed to occur as a result of oxidative modifications to DNA, RNA, lipids, and proteins .
We hypothesize that, 3 h following TBI, the increased levels of ROS previously observed in this model result in the oxidative modification of mitochondrial-related proteins and could possibly lead to their inactivation. To investigate this hypothesis, we used proteomics to identify mitochondrial fraction proteins that were significantly oxidized following 3 h post-TBI. Our results demonstrate that pyruvate dehydrogenase, voltage-dependent anion channel, fumarate hydratase 1, ATP synthase H ϩ transporting protein, prohibitin, cytochrome C oxidase Va, isovaleryl coenzyme A dehydrogenase, enolase-1, and glyceraldehyde-3-phosphate dehydrogenase are some of the key mitochondrial proteins that undergo acute oxidative modification following experimental TBI. In addition, the observed reduction in the activities of PDH, complex I, and complex IV confirm the notion that oxidative modification of key proteins may lead to their inactivation and loss in function.
METHODS

Animal and Surgical Procedures
All procedures using animals were approved by the University of Kentucky Animal Use and Care Committee. Twenty young adult (250-300 g), male SpragueDawley rats pooled (Harlan Laboratories, IN) giving n ϭ 5 were used in these experiments. All animals were housed in group cages on a 12-h light/dark cycle with free access to water and food. Animals were subjected to a moderate unilateral cortical contusion as previously described (Sullivan et al., , 2000a . This cortical contusion results in severe behavioral deficits, significant loss of cortical tissue, blood-brain barrier disruption, and a loss of hippocampal neurons (Sullivan et al., 2002) , mimicking some of the events that take place in human closed-head injury. Briefly, the subjects were anesthetized using isoflurane (2%) and placed in a stereotaxic frame (Kopf Instruments, Tujunga, CA). The head was positioned in the horizontal plane with the nose bar set at negative 5. Using sterile procedures, the skin was retracted, and a craniotomy was made with a hand-held trephine lateral to the sagittal suture and centered between Bregma and lambda. The skullcap was carefully removed without disrupting the underlying dura. The exposed brain was injured using a pneumatically controlled impacting device with a 5-mm beveled tip, which compressed the cortex at 3.5 m/sec to a depth of 1.5 mm (Baldwin et al., 1996; Sullivan et al., 1999) . After injury, Surgicel (Johnson and Johnson, Arlington, TX) was laid on the dura, and the skullcap was replaced. A thin coat of dental acrylic was then spread over the craniotomy site and allowed to dry before the wound was stapled closed PROTEOMIC IDENTIFICATION OF OXIDIZED MITOCHONDRIAL PROTEINS AFTER TBI and isoflurane nose cone removed. Core body temperature was monitored and maintained during the procedure and subsequent recovery (until the animals were freely moving around their cages) at 37°C. After 3 h, animals were then decapitated, and the brains were rapidly removed and dissected.
Mitochondria Isolation
Isolation of total mitochondria was carried out as previously described (Sullivan et al., 2003 (Sullivan et al., , 2004a . The animals were decapitated at 3 h post-surgery, and the brains carefully removed and placed in ice cold isolation buffer (215 mM mannitol, 75 mM sucrose, 0.1% bovine serum albumin [BSA] , 20 mM HEPES, 1 mM EGTA, and pH is adjusted to 7.2 with KOH). All subsequent steps were conducted at 4°C. In order to standardize the sampling of cortical tissue, a stainless steel tissue punch (8-mm-diameter) centered on the impact site was used to extract the cortical tissue (or the corresponding region of contralateral cortex), and then the ipsilateral and contralateral hippocampi were dissected out. The extracted tissue was homogenized, the homogenate was centrifuged at 1300ϫ g for 5 min at 4°C, and the supernatant was transferred to new tubes. The supernatants were then topped off with isolation buffer and centrifuged at 13,000ϫ g for 10 min. The resulting pellet was resuspended in isolation buffer and synaptic mitochondria released using nitrogen decompression as previously described (Sullivan et al., 2003; Brown et al., 2004; Sullivan et al., 2004a,b) . The final mitochondrial pellet was resuspended in an equal volume of 30% Percoll in isolation buffer. The resultant homogenate was layered on a discontinuous Percoll gradient with the bottom layer containing 40% Percoll solution in isolation buffer, followed by a 24% Percoll solution, and finally the sample in a 15% Percoll solution. The density gradients were spun in a Sorvall RC-5C plus super-speed refrigerated centrifuge (Asheville, NC) in a fixed angle SE-12 rotor at 30,400ϫ g for 10 min. Following centrifugation, band 3 (Sims, 1990) was removed from the density gradient and washed by centrifugation at 16,700ϫ g for 15 min. In order to obtain as pure a mitochondrial sample as possible, the supernatant was discarded, and the mitochondrial pellet was again resuspended in the 1 mL of isolation buffer and an equal volume of 30% Percoll. The homogenate was then added to a discontinuous Percoll density gradient, and centrifugation was performed as described above. Band 3 was obtained from the gradients, and 10 mL of isolation buffer without EGTA was added. The fractions were centrifuged at 16,700ϫ g for 15 min and subsequently at 11,000ϫ g for 10 min. The resultant pellet was resuspended in 1 mL of isolation buffer without EGTA and centrifuged at 10,000ϫ g for 10 min. The final mitochondrial pellet was resuspended in isolation buffer without EGTA to yield a protein concentration of ϳ10 mg/mL and stored on ice for respiration assays or resuspended in lysis buffer (10 mM HEPES, 137 mM NaCl, 4.6 mM KCl, 1.1 mM KH 2 PO 4 , 0.6 mM MgSO 4 and 0.5 mg/mL leupeptin, 0.7 g/mL pepstatin, 0.5 g/mL trypsin inhibitor, and 40 g/mL PMSF) for proteomic assays. Protein concentration was assayed using the Pierce BCA method.
Mitochondria Respiration Assay
Mitochondrial oxygen consumption was measured by using a Clark-type electrode in a continuously stirred, thermostated sealed chamber (Oxytherm System; Hansatech Instruments Ltd.) at 37°C as previously described (Brown et al., 2004; Jin et al., 2004; Sullivan et al., 2004a,b) . Isolated mitochondrial protein (ϳ30 g) was suspended in respiration buffer (215 mM mannitol, 75 mM sucrose, 20 mM HEPES, 2 mM MgCl 2 , 2.5 mM inorganic phosphate, 0.1% BSA, pH 7.2) in a final volume of 0.25 mL. The respiratory control ratio (RCR) was calculated as the ratio of oxygen consumption in the presence of 10 mM pyruvate and 5 mM malate or 10 mM succinate in the presence of ADP (state III) and in the absence of ADP (state IV).
Measurement of Protein Carbonyls
Protein carbonyls are an index of protein oxidation and were determined as described previously (Butterfield and Stadtman, 1997) . Briefly, the mitochondrial samples, n ϭ 5 (5 g of protein), were derivatized with 10 mM 2,4-dinitrophenylhydrazine (DNPH) in the presence of 5 L of 12% sodium dodecyl sulfate (SDS) for 20 min at room temperature (23°C). The samples were then neutralized with 7.5 L of the neutralization solution (2 M Tris in 30% glycerol). Derivatized protein samples were then blotted onto a nitrocellulose membrane with a slot-blot apparatus (250 ng per lane). The membrane was then washed with wash buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween-20) and blocked by incubation in the presence of 5% BSA, followed by incubation with rabbit polyclonal anti-DNPH antibody (1:100 dilution) as the primary antibody for 1 h. The membranes were washed with wash buffer and further incubated with alkaline phosphatase-conjugated goat anti-rabbit antibody as the secondary antibody for 1 h. Blots were developed using fast tablet (BCIP/NBT; Sigma-Aldrich) and quantified using Scion Image (PC version of Macintosh-compatible NIH Image) software.
Measurement of 3-Nitrotyrosine
Nitration of proteins is another form of protein oxidation . The nitrotyrosine content was determined immunochemically as previously described OPII ET AL. (Drake et al., 2003) . Briefly, samples were incubated with Laemmli sample buffer in a 1:2 ratio (0.125 m Trizma base, pH 6.8, 4% SDS, 20% glycerol) for 20 min. Protein (250 ng) was then blotted onto the nitrocellulose paper using the slot-blot apparatus and immunochemical methods as described above for protein carbonyls. The mouse anti-nitrotyrosine antibody (5:1000 dilutions) was used as the primary antibody, and alkaline phosphataseconjugated anti-mouse secondary antibody was used for detection. Blots were then scanned using scion imaging, and densitometric analysis of bands in images of the blots was used to calculate levels of 3-nitrotyrosine (3-NT).
Measurement of 4-Hydroxynonenal
4-Hydroxynonenal (HNE) is a marker of lipid oxidation, and the assay was performed as previously described (Lauderback et al., 2001) . Briefly, 10 L of sample were incubated with 10 L of Laemmli buffer containing 0.125 M Tris base pH 6.8, 4% (v/v) SDS, and 20% (v/v) glycerol. The resulting sample (250 ng) was loaded per well in the slot-blot apparatus containing a nitrocellulose membrane under vacuum pressure. The membrane was blocked with 3% (w/v) BSA in phosphate-buffered saline containing 0.01% (w/v) sodium azide and 0.2% (v/v) Tween-20 (PBST) for 1 h and incubated with a 1:5000 dilution of anti-4-hydroxynonenal (anti-HNE) polyclonal antibody in PBST for 90 min. Following completion of the primary antibody incubation, the membranes were washed three times in PBST. An anti-rabbit IgG alkaline phosphatase secondary antibody was diluted 1:8000 in PBST and added to the membrane. The membrane was washed in PBST three times and developed using SigmaFast tablets (BCIP/NBT substrate). Blots were dried, scanned with Adobe Photoshop, and quantified using Scion Image.
Two-Dimensional Electrophoresis
Mitochondrial proteins (200 g) were incubated with four volumes of 2N HCL at room temperature for electrophoresis or 20 mM DNPH for Western blotting at room temperature for 20 min. Proteins were concentrated through precipitation by the addition of ice-cold 100% trichloroacetic acid (TCA) to obtain a final concentration of 15% TCA. Samples were then placed on ice for 10 min, and precipitates were centrifuged at 16,000ϫ g for 3 min. The resulting pellet was then washed three times with a 1:1 (v/v) ethanol/ethyl acetate solution. The samples were then suspended in 200 L of rehydration buffer composed of a 1:1 ratio (v/v) of the Zwittergent solubilization buffer (7M urea, 2M thiourea, 2% Chaps, 65 mM DTT, 1% Zwittergent 0.8% 3-10 ampholytes and bromophenol blue) and ASB-14 solubilization buffer (7M urea, 2M thiourea 5Mn TCEP, 1% [w/v] ASB-14, 1% [v/v] Triton X-100, 0.5% Chaps, 0.5% 3-10 ampholytes) for 1 h.
First-Dimension Electrophoresis
For the first-dimension electrophoresis, 200 L of sample solution was applied to a 110-mm, pH 3-10, ReadyStrip™ IPG strip (Bio-Rad, Hercules, CA). The strips were then actively rehydrated in the protean IEF cell (Bio-Rad) at 50 V for 18 h. The isoelectric focusing was performed in increasing voltages as follows; 300 V for 1 h, then linear gradient to 8000 V for 5 h, and finally 20 000 V/h. Strips were then stored at Ϫ80°C until the second-dimension electrophoresis was to be preformed.
Second-Dimension Electrophoresis
For the second dimension, the IPG Strips, pH 3-10, were equilibrated for 10 min in 50 mM Tris-HCl (pH 6.8) containing 6 M urea, 1% (w/v) SDS, 30% (v/v) glycerol, and 0.5% dithiothreitol, and then re-equilibrated for 15 min in the same buffer containing 4.5% iodacetamide instead of dithiothreitol. Linear gradient pre-cast criterion Tris-HCl gels (8-16%) 13.3 cm ϫ 8.7 cm (W ϫ L; Bio-Rad) were used to perform second-dimension electrophoresis. Precision Protein™ Standards (Bio-Rad, CA) were run along with the sample at 200 V for 65 min.
SYPRO Ruby Staining
After the second-dimension electrophoresis, the gels were incubated in fixing solution (7% acetic acid, 10% methanol) for 20 min and stained overnight at room temperature with 50 mL of SYPRO Ruby gel stain (Bio-Rad). The SYPRO ruby gel stain was then removed, and gels were stored in deionized water.
Western Blotting
Mitochondrial proteins (200 g) incubated with 20 mM DNPH were used for Western blotting. The strips and gels were run as described above. After the second dimension, the proteins from the gels were transferred onto nitrocellulose papers (Bio-Rad) using the TransblotBlot ® SD semi-Dry Transfer Cell (Bio-Rad), at 15 V for 4 h. The 2,4-dinitrophenyl hydrazone (DNP) adduct of the carbonyls of the proteins was detected on the nitrocellulose paper using a primary rabbit antibody (Chemicon, CA) specific for DNP-protein adducts (1:100), and then a secondary goat anti-rabbit IgG (Sigma, MO) antibody was applied. The resulting stain was developed by application of Sigma-Fast (BCIP/NBT) tablets.
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Image Analysis
The nitrocellulose blots (oxyblots) were scanned and saved in TIFF format using Scanjet 3300C (Hewlett Packard, CA). SYPRO ruby-stained gel images were obtained using a STORM phosphoimager (Ex. 470 nm, Em. 618 nm; Molecular Dynamics, Sunnyvale, CA) and also saved in TIFF format. PD-Quest (Bio-Rad) imaging software was then used to normalize the gels and blots using the total spot density option, match and analyze visualized protein spots among differential 2D gels and 2D oxyblots, with one blot and one gel for each individual sample. The spot intensity of the gel corresponded to the protein levels, while the spot intensity if the blot corresponded to the carbonyl levels.
In-Gel Trypsin Digestion
Samples were digested by trypsin using protocols previously described and modified by Thongboonkerd et al. (2002) . Briefly, spots of interest were excised using a clean blade and placed in Eppendorf tubes, which were then washed with 0.1 M ammonium bicarbonate (NH 4 HCO 3 ) at room temperature for 15 min. Acetonitrile was then added to the gel pieces and incubated at room temperature for 15 min. This solvent mixture was then removed, and gel pieces were dried. The protein spots were then incubated with 20 L of 20 mM DTT in 0.1 M NH 4 HCO 3 at 56°C for 45 min. The DTT solution was removed and replaced with 20 L of 55 mM iodoacetamide in 0.1 M NH 4 HCO 3 . The solution was then incubated at room temperature for 30 min. The iodoacetamide was removed and replaced with 0.2 mL of 50 mM NH 4 HCO 3 and incubated at room temperature for 15 min. Acetonitrile (200 L) was added. After 15 min of incubation, the solvent was removed, and the gel spots were dried in a flow hood for 30 min. The gel pieces were rehydrated with 20 ng/L-modified trypsin (Promega, Madison, WI) in 50 mM NH 4 HCO 3 with the minimal volume enough to cover the gel pieces. The gel pieces were incubated overnight at 37°C in a shaking incubator.
Mass Spectrometry
A MALDI-TOF mass spectrometer in the reflectron mode was used to generate peptide mass fingerprints. Peptides resulting from in-gel digestion with trypsin were analyzed on a 384-position, 600-m AnchorChip™ Target (Bruker Daltonics, Bremen, Germany) and prepared according to AnchorChip recommendations (AnchorChip Technology, rev. 2, Bruker Daltonics, Bremen, Germany). Briefly, 1 L of digestate was mixed with 1 L of alpha-cyano-4-hydroxycinnamic acid (0.3 mg/mL in ethanol/acetone, 2:1 ratio) directly on the target and allowed to dry at room temperature. The sample spot was washed with 1 L of a 1% TFA solution for approximately 60 sec. The TFA droplet was gently blown off the sample spot with compressed air. The resulting diffuse sample spot was recrystallized (refocused) using 1 L of a solution of ethanol/acetone: 0.1% TFA (6:3:1 ratio). Reported spectra are a summation of 100 laser shots. External calibration of the mass axis was used for acquisition and internal calibration using either trypsin autolysis ions or matrix clusters and was applied post-acquisition for accurate mass determination.
Analysis of Peptide Sequences
Peptide mass fingerprinting was used to identify proteins from tryptic peptide fragments by utilizing the MASCOT search engine based on the entire NCBI and SwissProt protein databases. Database searches were conducted allowing for up to one missed trypsin cleavage and using the assumption that the peptides were monoisotopic, oxidized at methionine residues, and carbamidomethylated at cysteine residues. Mass tolerance of 150 ppm, 0.1-Da peptide tolerance, and 0.2-Da fragmentation tolerance was the window of error allowed for matching the peptide mass values. Probability-based MOWSE scores were estimated by comparison of search results against estimated random match population and were reported as Ϫ10*log10 (p), where p is the probability that the identification of the protein is a random event. MOWSE scores greater than 63 were considered to be significant (p Ͻ 0.05). All protein identifications were in the expected size and isoelectric point (pI) range based on the position in the gel.
Immunoprecipitation
Immunoprecipitation of specific proteins was performed as previously described (Sultana et al. 2004) . Mitochondria samples (200 g) from control or injured animals were incubated overnight at 4°C with respective antibodies for the identified proteins. The antibodyantigen complexes were collected with protein A/GSepharose-conjugated beads. This was followed by three washing steps with buffer B (50 Mm Tris Hcl [pH 8.0], 150 Mm NaCl, and 1% NP40). The proteins were resolved by SDS-PAGE followed by immunoblotting on a nitrocellulose membrane (Bio-Rad). The proteins were then detected with alkaline phosphate labeled secondary antibody (Sigma).
Statistical Analysis
Statistical analysis of specific protein carbonyl levels matched with anti-DNP-positive spots on 2D-oxyblots from mitochondria from the ipsilateral cortex (IC) and OPII ET AL. ipsilateral hippocampus (IH) with contralateral cortex (CC) and hippocampus (CH), was carried out using Student's t-tests. That is, each animal served as its own control, the contralateral side being the control for the ipsilateral side. A value of p Ͻ 0.05 was considered statistically significant. Only proteins that are considered significantly different by Student's t-test were subjected to in-gel trypsin digestion and subsequent proteomic analysis. This is the normal procedure for most proteomics studies (Maurer et al., 2005) .
Complex I Assay
Complex I activity was measured in isolated mitochondria as the rotenone-sensitive decrease in NADH absorption at 340 nm with ubiquinone-1 as the final acceptor, as previously described (Sriram et al., 1998; Sullivan et al., 2004a-c) with some slight modifications. Briefly, mitochondria were freeze-thawed and sonicated three times, and diluted 1 g/L in 10 mM K 3 PO 4 buffer. The assay was performed in 25 mM K 3 PO 4 buffer (pH 7.2) containing mitochondrial protein (6 g), 5 mM MgCl 2 , 1 mM KCN, 1 mg/mL BSA, and 150 M NADH. The reaction was preincubated for 2 min at 30°C, the baseline established, and the reaction initiated by addition of coenzyme Q-1 (50 M). The activity was measured by monitoring NADH fluorescence (340 nm excitation, Ͼ450 nm emission) over time under the same conditions as described above. The assay was also performed in the presence of rotenone (10 M the rotenone-insensitive activity and the rotenone-sensitive complex I enzyme activity calculated by subtracting the rotenone-insensitive activity from the total activity. All the assay protocol for a 96-well plate performed with BioTek (Winooski, VT) Synergy HT plate reader.
PDHC Assay
PDHC activity was measured using increment in fluorescence measurement of NADH with BioTek Synergy HT plate reader as previously described with slight modification (Starkov et al., 2004) . Briefly, mitochondria were freeze thawed and sonicated for three cycles. About 8 g of double Ficoll gradient purified mitochondrial protein was added into the buffer containing final concentration of 50 mM KCl, 10 mM HEPES, pH 7.4, 0.3 mM thiamine pyrophosphate (TPP), 10 M CaCl 2 , 0.2 mM MgCl 2 , 5 mM pyruvate, 1 M rotenone and 0.2 mM NAD ϩ . Reaction was started by addition of 0.14 mM CoASH, assay was performed at Ex 340 nm/Em 460 nm, and increase in fluorescence was observed at 1-min interval at 30°C. The PDHC activity was calculated and expressed as nmol/mg protein.
Complex IV Assay
Cytochrome c oxidase (complex IV) of mitochondrial electron transport chain component activity was measured with slight modification using BioTek Synergy HT plate reader as previously described (Wharton et al., 1967) . Briefly, mitochondria were freeze thawed and sonicated for three cycles. About 8 g of double Ficoll gradient purified mitochondrial protein were added into the 10 mM K 3 PO 4 buffer pH 8.0, 50 M reduced cytochrome c, and the decrease in absorbance was observed with difference with and without addition of cytochrome c at 1 min interval at 37°C at 550 nm. First, the rate constant k was calculated for oxidation reaction of ferricytochrome c, and then specific activity was expressed as (k/mg protein) for cytochrome c oxidase.
RESULTS
Mitochondria Respiration Assay following TBI
Mitochondrial bioenergetics was measured following TBI. As illustrated in Figure 1 , mitochondria isolated 3 h post-injury from the ipsilateral cortex of TBI animals show a reduction in the rate of respiration in the presence of ADP (state III) or FCCP (state V) compared to mitochondria isolated from contralateral cortex or shamoperated animals. Mitochondria from TBI animals demonstrated a significant reduction in state III respiration and a significant loss in the electron transport chain (ETC) capacity, as measured by the rate of respiration in the presence of the uncoupler FCCP (state V; in excess) when driven by the complex-I substrates pyruvate/malate or the complex-II substrate succinate (Fig. 1B) . No difference in respiration rates were observed between con-OPII ET AL. tralateral mitochondria or mitochondria isolated from sham-operated animals (Fig. 1B) . It is also apparent that the loss in bioenergetics was not due to a disruption in the inner membrane, since states II and IV (absence of ADP) are not significantly altered, indicating that a loss of ADP phosphorylation and ETS activity was the underlying cause. The respiratory control ratios (RCR) were also measured as illustrated in Figure 1C . There was a significant decline in the oxygen consumption in mitochondria isolated 3 h post-injury from the ipsilateral cortex compared to mitochondria isolated from contralateral cortex or sham-operated animals.
778
Measurement of Oxidative Stress Levels from Mitochondria Isolated after TBI
To determine if the cause of this loss of ETS activity and bioenergetics could be related to oxidative damage to the mitochondrial proteins, the level of protein carbonyls, 3NT, and HNE, as indicators of oxidative stress were measured in mitochondrial proteins isolated from the cortex and hippocampus of TBI animals. Figure 2 shows that, following TBI, there is a significant increase in the levels of 3NT, HNE, and protein carbonyls measured from mitochondria isolated from the ipsilateral hippocampus (IH) compared to the contralateral (CH) hippocampus. Figure 3 shows that the levels of 3NT, HNE, and protein carbonyl from the cortical IC versus CC were increased, but these changes were not significant. Together, these results extend previous findings of an increase protein and lipid oxidation following TBI (Braughler et al., 1992; Sullivan et al., 1998a Sullivan et al., ,b, 1999 Sullivan et al., , 2000a Lifshitz et al., 2004) . As mentioned earlier, the neurological dysfunction observed following TBI is a combination of both apoptotic and necrotic events. However, it should be noted that there are histopathological regional differences between the cortex and hippocampus following TBI with one pathway being predominant and the other depending on the region sampled. Cortical damage following experimental TBI has been shown to result primarily from necrosis, while the hippocampus has delayed neuronal death that is primarily apoptotic. We sampled these two regions for our proteomic studies. We, however, did not differentiate the pathways leading to the respective loss in mitochondrial function observed since mitochondrial bioenergetics studies were only performed on the mitochondria isolated from cortical tissue.
Proteomics Analysis of Mitochondrial Proteins from the Hippocampus and Cortex following TBI
Proteomics has previously been used to identify brain proteins that have undergone oxidative modifications in different human diseases and models thereof (Butterfield and Castegna, 2003; Butterfield and Boyd-Kimball, 2004; Butterfield et al., 2004) . Here, we used a similar approach, with slight modifications, to identify oxidized mitochondrial proteins following TBI. Protein oxidation levels in the mitochondria isolated from the cortex and hippocampus were measured by identifying carbonylated proteins using anti-DNPH immunochemical detection of 2D-oxyblots (Figs. 4A and 5A ). Using PD-Quest (Bio-Rad) imaging software, protein spots were matched between 2D-PAGE maps and the 2D-oxyblots. The immunoreactivity of each spot was normalized using total spot density option to the protein content in the 2D-PAGE (Figs. 4B and 5B). Only protein spots that showed a significant increase in protein carbonylation in the ipsilateral side compared to the contralateral side were excised from the gels and subjected to in-gel trypsin digestion. Tables 1 and 2 summarize the levels of oxidation for individual proteins.
Mass Spectroscopy Analysis of Mitochondrial Proteins from the Hippocampus and Cortex
Mass spectrometry analysis and data base searches allowed for the identification of these protein spots from OPII ET AL. the cortex (Table 3 ) and hippocampus (Table 4) . From the cortex, the following mitochondrial proteins were identified as being oxidatively modified in TBI: pyruvate dehydrogenase, voltage-dependent anion channel-2 (VDAC-2), fumarate hydratase 1, ATP synthase H ϩ transporting F1 alpha subunit, all of which are proteins involved in ATP production, transport or the activity of the ETS, and prohibitin. From the hippocampus, cytochrome C oxidase Va, isovaleryl coenzyme A dehydrogenase, enolase-1, and glyceraldehyde-3-phosphate dehydrogenase were identified as being oxidatively modified in TBI. The probability of a random identification is exceedingly low (Tables 3 and 4) .
Validation of Identified Protein Spots
Prior experience from our laboratory has demonstrated validation of each proteomic-identified protein by immunochemical means with no exceptions. VDAC-2 was probed with anti-VDAC antibody. Validation of VDAC-2 through Western blot analysis (Fig.  6B) and immunoprecipitation (Fig. 6C) is shown. Thus, we are confident that the protein identifications reported are correct.
Complex I, Complex IV, and PDH Activities
The activities of complex I, complex IV, and pyruvate dehydrogenase (PDH) were measured following 3 h post-TBI. As shown in Figure 7A ,B, there is a significant decline in the activities of complex I and complex IV, respectively, from the mitochondria isolated from ipsilateral cortex compared to those isolated from contralateral cortex. Figure 7C , on the other hand, illustrates the enzymatic activity of PDH. As shown, there was a decline in the activities of PDH following TBI from mitochondria isolated from the ipsilateral cortex compared to mitochondria isolated from the contralateral cortex; however, this decline in activity was not significant. These results confirm our previous findings showing that the loss in mitochondrial bioenergetics observed is most likely due to a decline in the activities of the ETC complexes.
DISCUSSION
The present study demonstrates that, following TBI, critical mitochondrial fraction proteins from the cortex PROTEOMIC IDENTIFICATION OF OXIDIZED MITOCHONDRIAL PROTEINS AFTER TBI 781 and hippocampus involved in energy metabolism are susceptible to oxidative damage and hence inactivation. We demonstrate that these proteins are significantly and rapidly oxidized, presenting a possible mechanism for the decreased mitochondrial bioenergetics as seen particularly in the cortical mitochondria following TBI. Following TBI, there is an increase in the production of ROS (Braughler et al., 1992; Sullivan et al., 1998 Sullivan et al., , 1999 Sullivan et al., , 2000a Lewen et al., 2001; Lifshitz et al., 2004) . It is also well established that ROS contribute to neuropathological events observed following TBI and other brain injury models (Sullivan et al., 1998 (Sullivan et al., , 2002 (Sullivan et al., , 2005 Fiskum et al., 2003; Martin et al., 2005) . Following experimental TBI, there is reduced mitochondrial bioenergetics. This loss in the capacity of the ETC to consume oxygen has been shown to be an etiology observed in most CNS injuries (Lifshitz et al., 2004; Sullivan et al., 2005) . The present study extends these findings to show elevated oxidative stress levels following TBI, a decline in cortical mitochondrial bioenergetics, and is the first to report the identification of specific mitochondrial-related proteins that are significantly oxidized following TBI. In addition, we show that there is a significant decline in the activities of key electron transport chain complexes, in particular complex I and complex IV and a decline in the activity of pyruvate dehydrogenase. These we believe are as a result of oxidative modification of key mitochondrial-related proteins following experimental TBI and are discussed below with relevance to possible mechanisms occurring after TBI. Pyruvate dehydrogenase (PDH) is a mitochondrial enzyme complex that catalyzes the conversion of pyruvate to acetyl CoA, NADH, and CO 2 , making this protein the central link between glycolysis and the TCA cycle (Zaidan et al., 1998; Martin et al., 2005) . Inactivation of PDH and its deficiency has been reported in several neurodegenerative disorders, leading to metabolic failure, secondary lactic acidosis, and production of ROS (Sorbi et al., 1983; Sheu et al., 1985; De Meirleir et al., 1993; Lavoie et al., 1995; Zaidan et al., 1998; Bogaert et al., 2000; Hard et al., 2001; Pocernich et al., 2003; Rosenthal et al., 2003) . One mechanism for inactivation of PDH has been hypothesized to be the oxidative modification of the enzyme, involving possible site-specific protein oxidation of critical sulfhydryl groups (Tabatabaie et al., 1996) or possibly due to metal-catalyzed oxidation of susceptible amino acids (Bogaert et al., 1994) . In the present study, we have shown that PDH is one of the key proteins to be significantly ox-OPII ET AL. idized following TBI, in addition, we have also shown that though not significant, there is a decline in the activity of PDH in mitochondria isolated from ipsilateral cortex compared to those isolated from contralateral cortex and shamoperated animals following TBI. As a consequence of these events, the activity of complex I was also found to be decreased, this would therefore disrupt the supply of NADH, a required substrate for complex I, contributing to the NADH-linked impaired mitochondrial bioenergetics as seen in Figure 1 There was a significant decline in the activities of complex IV following traumatic brain injury (TBI) in the ipsilateral cortex (IC) compared to the contralateral cortex (CC). There was also a reduction in the activities of complex I and the activity of PDH, though not significant. brane of eukaryotes (Yoo et al., 2001) . VDAC and adenine nucleotide translocator (ANT) mediate the exchange of adenine nucleotides between the cytosol and the matrix (Vander Heiden et al., 2000) . VDAC also is hypothesized to form part of the mPTP, which mediates the release of cytochrome C from the mitochondria in early events occurring in TBI (Sullivan et al., 2002) . In the present study, VDAC-2 is significantly oxidized following TBI. In one way, this oxidation could possibly lead to a conformational change of the porin, inhibiting the exchange of ATP-ADP, thus compromising cellular energetics. Another possible effect of the oxidation of VDAC could be the disruption of Ca 2ϩ homeostasis leading to a lower Ca 2ϩ threshold for depolarization, collapse of mitochondrial membrane potential and ultimately the alteration of mitochondrial permeability swelling and eventual rupture of the outer mitochondrial membrane (OMM) and release of cytochrome c.
ATP synthase (complex V) is a mitochondrial enzyme that utilizes the electrochemical proton gradient established across the inner mitochondrial membrane by the ETC for synthesis of ATP (Leyva et al., 2003) . ATP synthase deficiency has been associated with an increase in oxidative stress (Basso et al., 2004) and is a target for cysteine oxidation during renal oxidative stress (Eaton et al., 2003) . Our laboratory has shown that ATP synthase is oxidatively modified and inactivated in the gracile axonal dystrophy (gad) mouse brain . In the present study, ATP synthase F1 ␣ subunit was significantly oxidized following TBI. Oxidation of this enzyme could presumably result in its inactivation, compromising crucial cellular process of ATP generation reported following TBI (Hovda et al., 1992; Sullivan et al., 1998 Sullivan et al., , 2000a .
Cytochrome C oxidase (COx) is the terminal enzyme complex of the ETC that transfers reducing equivalents from cytochrome C to oxygen (Harris et al., 2001 ). COx deficiency is associated with Leigh syndrome, FrenchCanadian type (LSFC)-a condition characterized by recurrent episodes of acute and often fatal metabolic acidosis-and has recently been associated with stressinduced apoptosis and degenerative diseases (Kadenbach et al., 2004) . Gene expression and activity of COx in various models of TBI have also been extensively established, providing evidence for the reduction in activity of COx after TBI (LaManna et al., 1981; Hovda et al., 1991; Harris et al., 2001) .
In the present study, we identified COx Va, as one of the proteins that was significantly oxidized. In addition, we have shown that the activity of complex IV is significantly decreased following TBI. As a result, being the terminal complex of the ETC, COx is a key site in the regulation of energy metabolism. Its oxidative modification and hence its inactivation could therefore lead to backup of electrons in the ETC with consequent increase mitochondrial ROS production and compromised ATP generation. These effects could be part of the mechanism of neurodegeneration and loss of mitochondrial bioenergetics observed after TBI.
Enolase interconverts 2-phosphoglycerate to phosphoenolpyruvate, while glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyzes the oxidation of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate and NADH. Other than its role in glycolysis, recent studies now support the idea of diverse activities for GAPDH. Emerging roles include membrane fusion and transport, accumulation of glutamate into presynaptic vesicles, and acting as a cellular sensor of oxidative stress, raising questions on its cellular localization (Chuang et al., 2004) . More recently, it has been shown that GAPDH also act as a sensor for NO stress (Hara et al., 2006) . Though enolase and GAPDH are not typical mitochondrial proteins, there is a possibility that this identification could possibly be from contaminations of our mitochondrial samples. However, evidence suggest that glycolytic proteins can be localized in the mitochondria (Liaud et al., 2000; Giege et al., 2003; Taylor et al., 2003; AzoulayZohar et al., 2004) . Such a localization is theoretically possible because most glycolytic enzymes have hydrophobic regions that could form membrane-spanning domains (Giege et al., 2003) . The purpose for this putative localization is not well understood, but studies speculate that mitochondrial residency would facilitate the interaction of glycolysis and the OMM to compensate for reductions in mitochondrial energy production (Giege et al., 2003) . This interaction would in effect provide pyruvate directly and at high concentrations for ATP generation.
GAPDH and enolase-dependent pathways are associated with different pathologies involving oxidative stress. Our laboratory previously identified ␣-enolase in brain from AD (Castegna et al., 2002) and in age-accelerated (SAMP8) mice (Poon et al., 2004) to be oxidatively modified. In the present study, enolase and GAPDH were significantly oxidized following TBI. Consistent with previous studies (Hensley et al., 1995; Sultana et al., 2004 Sultana et al., , 2006 oxidative modification of proteins among other post-translational modifications, leads to diminished activity which in this case would inhibit their glycolytic functions. Coupled to the loss of mitochondrial bioenergetics, this loss of activity would further lead to a reduction in ATP production and eventual cell death.
Fumarate hydratase (FH) is an enzyme of the TCA cycle that catalyzes the conversion of fumarate to L-malate (Tuboi et al., 1990; Pollard et al., 2003) , while isovaleryl coenzyme A dehydrogenase (IVD) is a nucleus-encoded OPII ET AL. mitochondrial flavoprotein involved in the leucine catabolism pathway, catalyzing the conversion of isovaleryl-CoA to 3-methylcrotonyl-CoA and providing electrons to the electron-transferring flavoprotein (ETF) for ATP synthesis (Mohsen et al., 1998; Volchenboum et al., 2000; Mohsen et al., 2001) . Recent mitochondrial proteomic studies on cardiomyocytes from chronic stressed rat, showed a decrease in energy metabolism and expression of FH-1 (Liu et al., 2004) . FH and IVD were among the mitochondrial proteins found in the current study to be oxidatively modified following TBI. The reduction in ATP levels following TBI could lead to dependence on alternative pathways, such as the leucine pathway, for the supply of substrates for energy production. Hence, the oxidation of FH and IVD would lead to the diminution of the TCA cycle function, with consequent inability to supply necessary substrates required for energy metabolism and an overall breakdown of bioenergetics as observed in TBI.
Prohibitin (PHB) is an evolutionarily conserved protein located in the inner mitochondria membrane. This protein acts as a chaperone in the assembly of subunits of mitochondrial respiratory chain complexes and stabilization of membrane proteins (Nijtmans et al., 2000 (Nijtmans et al., , 2002 . A mutation in the PHB gene leads to a decreased replicative lifespan in yeast, due to a decline in cellular metabolic capacity (Coates et al., 1997) . In higher organisms, therefore, disruption of PHB conceivably could have even greater metabolic effects.
Prohibitin expression is increased in apoptotic cells and can be induced by metabolic stress, possibly playing a role in regulation of mitochondrial respiratory activity (Liu et al., 2004) . PHB is therefore a critical mitochondrial protein required to maintain normal mitochondrial homeostasis. In the present study, we identified PHB as one of the brain mitochondrial proteins that was significantly oxidized. Though speculative, oxidation of prohibitin conceivably may disrupt its role in the assembly of ETC, contributing to a diminution of energy metabolism as observed following TBI.
The neuropathological events observed after TBI contribute cellular to damage and eventual neurological dysfunction. One mechanism of TBI-mediated neurodegeneration appears to involve mitochondria via an oxidative stress pathway (Sullivan et al., 2005) . It has been hypothesized that various mitochondrial proteins could be oxidatively modified and inactivated (Bogaert et al., 2000; Fiskum et al., 2004; Martin et al., 2005) . This current study is the first to use proteomics to provide novel insights into the mechanisms of oxidative mitochondrial damage after TBI. We have demonstrated that following experimental TBI and isolation of total mitochondria, there is a significant decline in cortical mitochondria bioenergetics and oxidative modification of key components of the ETC. Specifically, we have shown that the activities of PDH, complex I and complex IV are reduced following TBI. This continues to support the notion that oxidative modification of proteins tend to lead to their inactivation. The oxidation of these identified proteins are of significant importance, due to their involvement with the ETS and/or apoptotic pathways, as well as their roles in the maturation and assembly process of key mitochondrial proteins. The identification of these oxidatively modified proteins present the first causal evidence for the significant loss of mitochondrial function that has been demonstrated to occur after TBI. They may also provide new insights into the mechanism of cellular damage after TBI and also provide novel targets for potential therapeutic interventions in this significant health problem.
It should be noted however that considerable injury occurs even on the non-impacted side in the rodent CCI model, thus raising the potential concern of using the contralateral side as an internal control. However, as demonstrated in Figure 1 , illustrating studies in which we used mitochondria isolated from sham, contralateral, and ipsilateral sides, there are no significant differences in the respiratory rates or oxygen consumption. Based on this result, we believe that the use of the contralateral side as a control in this study is appropriate.
